Omicron variant: Pfizer starts clinical trial for modified Covid vaccine

Pfizer and BioNTech announced Tuesday that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the supercontagious

Powered by NewsAPI , in News on .

news image
Pfizer and BioNTech announced Tuesday that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the supercontagious
Read More